Clinical Neurology NewsThird course of alemtuzumab can improve MS outcomesFebruary 3, 2018Multiple Sclerosis
Clinical Neurology NewsSwitching RRMS patients to daclizumab beta appears safeFebruary 3, 2018Multiple Sclerosis
Clinical Neurology NewsVIDEO: Oral ozanimod shows promise for relapsing MSFebruary 3, 2018Multiple Sclerosis
Clinical Neurology NewsVIDEO: New MS ambulatory measure could fill clinical gapFebruary 3, 2018Multiple Sclerosis
Clinical Neurology NewsVIDEO: Alemtuzumab associated with long-term MS control in TOPAZ studyFebruary 3, 2018Multiple Sclerosis
Neurology ReviewsCan Newborn Screening for Krabbe Disease Lead to New Therapies?February 2, 2018Rare Diseases
Neurology ReviewsGenetic Screens Yield Potential Therapies for Neurodegenerative DiseasesFebruary 2, 2018Rare DiseasesPediatricsNeuromuscular DisordersAlzheimer's & Cognition
Clinical Neurology NewsMS may be a transmissible protein misfolding disorder, study suggestsFebruary 2, 2018Multiple Sclerosis
Clinical Neurology NewsNo improvement in sight for Alzheimer’s drug developmentFebruary 2, 2018Alzheimer's & Cognition
Clinical Neurology NewsVIDEO: Could targeting gut dysbiosis in MS prevent disease?February 2, 2018Multiple Sclerosis
Clinical Neurology NewsTicagrelor may be superior to clopidogrel in poor metabolizersFebruary 2, 2018Stroke
Clinical Neurology NewsTenecteplase surpasses alteplase for thrombolysing acute ischemic strokeFebruary 2, 2018Stroke
